Clinical Trial Update: 24 Hours Treatment with Alteplase in Patients with Ischemic Stroke [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating 24-hour alteplase treatment for ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Activase (alteplase)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Stroke | Phase 3 | Status: COMPLETED